Medicenna Therapeutics Corp (MDNAF) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab (Keytruda®), Mdna11 | Fallopian Tube Cancer, Cervical Cancer, Ovarian Cancer, Bladder Cancer, Advanced Solid Tumor, Triple Negative Breast Cancer, Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Solid Tumor, Gastric Cancer, Clear Cell Renal Cell Carcinoma, Cutaneous Melanoma, Msi-H Cancer, Cancer With A High Tumor Mutational Burden, Solid Tumor, Adult, Skin Cancer, Endometrial Cancer, Esophageal Cancer, Squamous Cell Carcinoma Of Head And Neck, Primary Peritoneal Cancer, Unresectable Solid Tumor, Mucosal Melanoma, Endometrial Carcinoma, Pleural Mesothelioma, Non-Small Cell Lung Cancer Squamous, Non-Small Cell Lung Cancer Non-Squamous, Colorectal Cancer (Msi-H), Msi-H Solid Malignant Tumor, Epithelial Ovarian Carcinoma, Gastroesophageal Junction (Gej) Cancer, Acral Melanoma, Dmmr Solid Malignant Tumor, Dmmr Cancer, Pancreas Adenocarcinoma (Msi-H), Viral Cancer, Cervical Cancers | phase1AndPhase2 | Recruiting | A Beta-only IL-2 ImmunoTherapY Study | Sep 10, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab (Keytruda®), Mdna11 | phase1AndPhase2 | Fallopian Tube Cancer, Cervical Cancer, Ovarian Cancer, Bladder Cancer, Advanced Solid Tumor, Triple Negative Breast Cancer, Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Solid Tumor, Gastric Cancer, Clear Cell Renal Cell Carcinoma, Cutaneous Melanoma, Msi-H Cancer, Cancer With A High Tumor Mutational Burden, Solid Tumor, Adult, Skin Cancer, Endometrial Cancer, Esophageal Cancer, Squamous Cell Carcinoma Of Head And Neck, Primary Peritoneal Cancer, Unresectable Solid Tumor, Mucosal Melanoma, Endometrial Carcinoma, Pleural Mesothelioma, Non-Small Cell Lung Cancer Squamous, Non-Small Cell Lung Cancer Non-Squamous, Colorectal Cancer (Msi-H), Msi-H Solid Malignant Tumor, Epithelial Ovarian Carcinoma, Gastroesophageal Junction (Gej) Cancer, Acral Melanoma, Dmmr Solid Malignant Tumor, Dmmr Cancer, Pancreas Adenocarcinoma (Msi-H), Viral Cancer, Cervical Cancers | Recruiting | A Beta-only IL-2 ImmunoTherapY Study | Sep 10, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Medicenna Therapeutics (MDNAF) have in its pipeline
Medicenna Therapeutics Corp MDNAF is currently developing the following drugs: Pembrolizumab (Keytruda®), Mdna11. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
